Table 3.

Odds ratios considering each of the 50 different global Shapley additive explanation value distributions from data covering the period 2001-2019.

ATCa class	ATC description	Odds ratiob (95% CI)	P value
c07aa05	Propranolol	1.94 (1.37-2.77)	<.001
n05cm09	Valerian	1.61 (1.15-2.25)	.01
c09aa02	Enalapril	1.34 (0.9-1.98)	.15
d11ax18	Diclofenac	1.33 (1.04-1.71)	.03
c10aa01	Simvastatin	1.3 (1-1.69)	.05
g01aa10	Clindamycin	1.22 (0.94-1.59)	.14
s01aa01	Chloramphenicol	1.19 (1.02-1.4)	.03
a02ba03	Famotidine	1.17 (0.97-1.42)	.10
r03ac03	Terbutaline	1.17 (0.86-1.59)	.32
b03ad01	Ferrous amino acid complex	1.15 (0.95-1.4)	.16
a10ba02	Metformin	1.14 (0.66-1.96)	.65
j01ce02	Phenoxymethylpenicillin	0.96 (0.82-1.11)	.58
r01ba52	Pseuroephedrine, combination	0.86 (0.73-1.02)	.07
s01ca01	Dexamethansone	0.8 (0.67-0.97)	.02
d07ac13	Mometasone	0.79 (0.63-0.98)	.04
d04aa13	Dimetindene	0.71 (0.54-0.92)	.01
n06ab05	Paroxetine	0.33 (0.2-0.57)	.001

^aATC: Anatomical Therapeutic Chemical classification system.

^bEffect estimates from conditional logistic regression accounting for the matched risk sets, with additional adjustment for the average frequency of physician visits and any history of diabetes, cardiovascular disease, or excess weight prior to the index date.